- Report
- August 2024
- 133 Pages
China
From €1577EUR$1,800USD£1,361GBP
- Report
- August 2024
- 101 Pages
China
From €1577EUR$1,800USD£1,361GBP
- Report
- January 2024
- 156 Pages
United States
€3329EUR$3,800USD£2,873GBP
- Report
- January 2024
- 114 Pages
United States
€3066EUR$3,500USD£2,646GBP
- Report
- January 2024
- 35 Pages
United States
- Report
- January 2024
- 109 Pages
United States
€3066EUR$3,500USD£2,646GBP
- Report
- July 2023
- 229 Pages
Global
From €3943EUR$4,500USD£3,402GBP
- Report
- January 2023
- 50 Pages
China
From €2628EUR$3,000USD£2,268GBP
- Report
- October 2022
- 115 Pages
Global
From €3504EUR$4,000USD£3,024GBP
- Report
- September 2021
- 40 Pages
China
From €2278EUR$2,600USD£1,966GBP
- Report
- June 2021
- 675 Pages
Global
From €3723EUR$4,250USD£3,213GBP
From €2278EUR$2,600USD£1,966GBP
From €2278EUR$2,600USD£1,966GBP
- Report
- June 2021
- 50 Pages
China
From €2278EUR$2,600USD£1,966GBP
- Report
- May 2021
- 50 Pages
China
From €2278EUR$2,600USD£1,966GBP
- Report
- April 2021
China
From €2278EUR$2,600USD£1,966GBP
- Report
- December 2018
- 30 Pages
China
From €1927EUR$2,200USD£1,663GBP
- Report
- July 2018
- 33 Pages
Global
From €8761EUR$10,000USD£7,561GBP
- Report
- July 2018
- 27 Pages
Global
From €8761EUR$10,000USD£7,561GBP
- Report
- February 2018
- 680 Pages
Global
From €19275EUR$22,000USD£16,633GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more